Buprenorphine Extended-Release Injection
INDV-6000-405
Approved small_molecule completed
Quick answer
Buprenorphine Extended-Release Injection for Opioid Use Disorder is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Opioid Use Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed